Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

BACKGROUND: The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) has recommended that isocitrate dehydrogenase 1 and 2 wildtype (IDH1/2wt) diffuse lower-grade gliomas (LGGs) World Health Organization (WHO) grade II or III that present with (i) a telomerase...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Tesileanu, C Mircea S, Dirven, Linda, Wijnenga, Maarten M J, Koekkoek, Johan A F, Vincent, Arnaud J P E, Dubbink, Hendrikus J, Atmodimedjo, Peggy N, Kros, Johan M, van Duinen, Sjoerd G, Smits, Marion, Taphoorn, Martin J B, French, Pim J, van den Bent, Martin J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Clinical Investigations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158657/
https://ncbi.nlm.nih.gov/pubmed/31637414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz200
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires